Violent suicidal behaviour in bipolar disorder is associated with nitric oxide synthase 3 gene polymorphism

Acta Psychiatrica Scandinavica

Volumn 132, Issue 3, 2015, Pages 218-225

  Oliveira, J ^a,b   Debnath, M ^a,b   Etain, B ^b,c,d,e   Bennabi, M ^a,b   Hamdani, N ^b,c,d,e   Lajnef, M ^b,c,d   Bengoufa, D ^a   Fortier, C ^a   Boukouaci, W ^a   Bellivier, F ^b,c,d,e   Kahn, J P ^b,f   Henry, C ^b,c,d,e   Charron, D ^a,b,g   Krishnamoorthy, R ^a   Leboyer, M ^b,c,d,e   Tamouza, R ^a,b,g  

^a SAINT LOUIS HOSPITAL   (France)

^b FONDATION FONDAMENTAL   (France)

^c INSERM U955   (France)

^d FACULTÉ DE MÉDECINE   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f CHU NANCY BRABOIS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Bipolar disorder; Nitric oxide synthase; Polymorphism; Suicidal behaviour

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, HUMAN; NOS2 PROTEIN, HUMAN; NOS3 PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DNA POLYMORPHISM; DSM-IV; FEMALE; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL PATIENT; NOS1 GENE; NOS2 GENE; NOS3 GENE; ONSET AGE; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; VIOLENCE; ENZYMOLOGY; GENETIC ASSOCIATION STUDY; GENETICS; MIDDLE AGED; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; SUICIDAL IDEATION;

ADULT; BIPOLAR DISORDER; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, SINGLE NUCLEOTIDE; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 84938740261     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/acps.12433     Document Type: Article

References (80)

1. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 2014;13:153-160.
2. Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013;70:931-939.
3. Latalova K, Kamaradova D, Prasko J. Suicide in bipolar disorder: a review. Psychiatr Danub 2014;26:108-114.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edn. Arlington, VA: American Psychiatric Association, 2013.
5. Roy A. Gene-environment interaction and suicidal behavior. In: Dwivedi Y, ed. The neurobiological basis of suicide, Chapter 10. Boca Raton, FL: CRC Press, 2012:195-212.
6. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 2010;12:1-9.
7. Spreux-Varoquaux O, Alvarez JC, Berlin I et al. Differential abnormalities in plasma 5-HIAA and platelet serotonin concentrations in violent suicide attempters: relationships with impulsivity and depression. Life Sci 2001;69:647-657.
8. Cremniter D, Jamain S, Kollenbach K et al. CSF 5-HIAA levels are lower in impulsive as compared to nonimpulsive violent suicide attempters and control subjects. Biol Psychiatry 1999;45:1572-1579.
9. Neves FS, Malloy-Diniz LF, Barbosa IG, Brasil PM, Corrêa H. Bipolar disorder first episode and suicidal behavior: are there differences according to type of suicide attempt? Rev Bras Psiquiatr 2009;31:114-118.
10. Akaike T, Maeda H. Nitric oxide and virus infection. Immunology 2000;101:300-308.
11. Dickerson F, Stallings C, Origoni A et al. Pentraxin 3 is reduced in bipolar disorder. Bipolar Disord 2014. doi: 10.1111/bdi.12281. [Epub ahead of print].
12. Pfaffenseller B, Fries GR, Wollenhaupt-Aguiar B et al. Neurotrophins, inflammation and oxidative stress as illness activity biomarkers in bipolar disorder. Expert Rev Neurother 2013;13:827-842.
13. Vargas HO, Nunes SOV, Pizzo de Castro M et al. Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts. J Affect Disord 2013;150:923-930.
14. Chiavegatto S, Dawson VL, Mamounas LA, Koliatsos VE, Dawson TM, Nelson RJ. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci USA 2001;98:1277-1281.
15. Kilic F, Murphy DL, Rudnick G. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 2003;64:440-446.
16. Kim Y-K, Paik J-W, Lee S-W, Yoon D, Han C, Lee B-H. Increased plasma nitric oxide level associated with suicide attempt in depressive patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1091-1096.
17. Kiss JP, Vizi ES. Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 2001;24:211-215.
18. Lee B-H, Lee S-W, Yoon D et al. Increased plasma nitric oxide metabolites in suicide attempters. Neuropsychobiology 2006;53:127-132.
19. Rujescu D, Giegling I, Mandelli L et al. NOS-I and -III gene variants are differentially associated with facets of suicidal behavior and aggression-related traits. Am J Med Genet B Neuropsychiatr Genet 2008;147B:42-48.
20. Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res 2014;218:61-68.
21. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999;1411:217-230.
22. Bauer V, Sotníková R. Nitric oxide-the endothelium-derived relaxing factor and its role in endothelial functions. Gen Physiol Biophys 2010;29:319-340.
23. Chiavegatto S, Nelson RJ. Interaction of nitric oxide and serotonin in aggressive behavior. Horm Behav 2003;44:233-241.
24. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991;14:60-67.
25. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997;94:5243-5248.
26. Tabatabaei SN, Girouard H. Nitric oxide and cerebrovascular regulation. Vitam Horm 2014;96:347-385.
27. Yarovinsky F. Innate immunity to Toxoplasma gondii infection. Nat Rev Immunol 2014;14:109-121.
28. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994;298(Pt 2):249-258.
29. Béchade C, Colasse S, Diana MA, Rouault M, Bessis A. NOS2 expression is restricted to neurons in the healthy brain but is triggered in microglia upon inflammation. Glia 2014;62:956-963.
30. Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacol Sci 2000;21:249-252.
31. Doyle CA, Slater P. Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus. Neuroscience 1997;76:387-395.
32. Oliveira RMW, Guimarães FS, Deakin JFW. Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders. Braz J Med Biol Res 2008;41:333-341.
33. Rao JS, Harry GJ, Rapoport SI, Kim HW. Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol Psychiatry 2010;15:384-392.
34. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-2012.
35. Petit JF, Schott C, Lepoivre M, Stoclet JC. Production of an arginine-derived relaxing factor induced by IFN-gamma plus endotoxin in murine adenocarcinoma EMT 6 cells. Biochem Biophys Res Commun 1990;173:1-5.
36. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996;271:C1424-C1437.
37. Dickerson FB, Boronow JJ, Stallings C et al. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 2004;55:588-593.
38. Fu ZF, Amsterdam JD, Kao M, Shankar V, Koprowski H, Dietzschold B. Detection of Borna disease virus-reactive antibodies from patients with affective disorders by western immunoblot technique. J Affect Disord 1993;27:61-68.
39. Hamdani N, Daban-Huard C, Lajnef M et al. Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord 2013;148:444-448.
40. Parboosing R, Bao Y, Shen L, Schaefer CA, Brown AS. Gestational influenza and bipolar disorder in adult offspring. JAMA Psychiatry 2013;70:677-685.
41. Reif A, Herterich S, Strobel A et al. A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry 2006;11:286-300.
42. Saur D, Vanderwinden J-M, Seidler B, Schmid RM, De Laet M-H, Allescher H-D. Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. Proc Natl Acad Sci USA 2004;101:1662-1667.
43. Weber H, Klamer D, Freudenberg F et al. The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. Eur Neuropsychopharmacol 2014;24:65-85.
44. Burgner D, Rockett K, Ackerman H et al. Haplotypic relationship between SNP and microsatellite markers at the NOS2A locus in two populations. Genes Immun 2003;4:506-514.
45. Fu L, Zhao Y, Lu J et al. Functional single nucleotide polymorphism-1026C/A of inducible nitric oxide synthase gene with increased YY1-binding affinity is associated with hypertension in a Chinese Han population. J Hypertens 2009;27:991-1000.
46. Burgner D, Usen S, Rockett K et al. Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria. Hum Genet 2003;112:379-386.
47. Jamieson SE, Miller EN, Black GF et al. Evidence for a cluster of genes on chromosome 17q11-q21 controlling susceptibility to tuberculosis and leprosy in Brazilians. Genes Immun 2004;5:46-57.
48. Martín MC, Martinez A, Mendoza JL et al. Influence of the inducible nitric oxide synthase gene (NOS2A) on inflammatory bowel disease susceptibility. Immunogenetics 2007;59:833-837.
49. Möller M, Nebel A, Valentonyte R, van Helden PD, Schreiber S, Hoal EG. Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberc 2009;89:189-194.
50. Joshi MS, Mineo C, Shaul PW, Bauer JA. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J 2007;21:2655-2663.
51. Vecoli C. Endothelial nitric oxide synthase gene polymorphisms in cardiovascular disease. Vitam Horm 2014;96:387-406.
52. Cui H, Supriyanto I, Asano M et al. A common polymorphism in the 3'-UTR of the NOS1 gene was associated with completed suicides in Japanese male population. Prog Neuropsychopharmacol Biol Psychiatry 2010;34:992-996.
53. Sáiz PA, García-Portilla MP, Paredes B et al. Lack of association between endothelial nitric oxide synthase (NOS3) gene polymorphisms and suicide attempts. Behav Brain Funct 2007;3:32.
54. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Paris: Masson, 1994.
55. Nurnberger JI Jr, Blehar MC, Kaufmann CA et al. Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH genetics initiative. Arch Gen Psychiatry 1994;51:849-859; discussion 863-864.
56. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
57. Bech P, Rafaelsen OJ, Kramp P, Bolwig TG. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978;17:430-431.
58. Maxwell ME. Manual for the family interview for genetic studies. NIMH, 1992.
59. Geoffroy PA, Etain B, Scott J, et al. Reconsideration of bipolar disorder as a developmental disorder: importance of the time of onset. J Physiol Paris 2013;107:278-285.
60. Mann JJ. Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003;4:819-828.
61. Asberg M, Träskman L, Thorén P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976;33:1193-1197.
62. Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 2011;8:1.
63. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978-989.
64. Stephens M, Scheet P. Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation. Am J Hum Genet 2005;76:449-462.
65. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-575.
66. Tesauro M, Thompson WC, Rogliani P, Qi L, Chaudhary PP, Moss J. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci USA 2000;97:2832-2835.
67. Veldman BA, Spiering W, Doevendans PA et al. The Glu298Asp polymorphism of the NOS 3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023-2027.
68. Amen DG, Prunella JR, Fallon JH, Amen B, Hanks C. A comparative analysis of completed suicide using high resolution brain SPECT imaging. J Neuropsychiatry Clin Neurosci 2009;21:430-439.
69. Willeumier K, Taylor DV, Amen DG. Decreased cerebral blood flow in the limbic and prefrontal cortex using SPECT imaging in a cohort of completed suicides. Transl Psychiatry 2011;1:e28.
70. Courtet P, Jollant F, Castelnau D, Buresi C, Malafosse A. Suicidal behavior: relationship between phenotype and serotonergic genotype. Am J Med Genet C Semin Med Genet 2005;133C:25-33.
71. Mann JJ, Brent DA, Arango V. The neurobiology and genetics of suicide and attempted suicide: a focus on the serotonergic system. Neuropsychopharmacology 2001;24:467-477.
72. Kessler P, Bauersachs J, Busse R, Schini-Kerth VB. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessels. Arterioscler Thromb Vasc Biol 1997;17:1746-1755.
73. Goldstein BI, Collinger KA, Lotrich F et al. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol 2011;21:479-484.
74. Jerrell JM, McIntyre RS, Tripathi A. A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. J Clin Psychiatry 2010;71:1518-1525.
75. Handley LJL, Manica A, Goudet J, Balloux F. Going the distance: human population genetics in a clinal world. Trends Genet 2007;23:432-439.
76. Okumura T, Kishi T, Okochi T et al. Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population. Neuropsychobiology 2010;61:57-63.
77. Gałecki P, Maes M, Florkowski A et al. Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. J Affect Disord 2011;129:175-182.
78. García-Bueno B, Bioque M, Mac-Dowell KS et al. Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull 2014;40:376-387.
79. Kim H-W, Cho S-C, Kim J-W et al. Family-based association study between NOS-I and -IIA polymorphisms and autism spectrum disorders in Korean trios. Am J Med Genet Part B Neuropsychiatr Genet 2009;150B:300-306.
80. Reif A, Strobel A, Jacob CP et al. A NOS-III haplotype that includes functional polymorphisms is associated with bipolar disorder. Int J Neuropsychopharmacol 2006;9:13-20.